Malignant Lip and Oral Cavity Neoplasm — Trials

Malignant Lip and Oral Cavity Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

554 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 149
Recruiting: 77
Ph III recruiting: 11
Growth YoY: +4.8%
Industry share: 5%
Top sponsor: National Cancer Institute (NCI)
Termination share: 26.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (53)

clinicaltrialsPublishedShowing 151–166 of 166 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00114283	Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer	completed	Phase 2	30	National Cancer Institute (NCI)NIH	1	Apr 15, 2015	clinicaltrials
NCT01790204	A Study of the Effects of PEITC on Oral Cells With Mutant p53	completed	Phase 1 / Phase 2	55	Georgetown UniversityOTHER	1	Mar 23, 2015	clinicaltrials